Ishita Drugs & Industries standalone net profit declines 23.33% in the June 2026 quarter

Sales decline 41.67% to Rs 3.15 crore

Net profit of Ishita Drugs & Industries declined 23.33% to Rs 0.23 crore in the quarter ended June 2026 as against Rs 0.30 crore during the previous quarter ended June 2025. Sales declined 41.67% to Rs 3.15 crore in the quarter ended June 2026 as against Rs 5.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3.15	5.40	-42
OPM %	9.84	6.48	-
PBDT	0.35	0.42	-17
PBT	0.30	0.39	-23
NP	0.23	0.30	-23

Powered by Capital Market - Live News